David R. Strayer

1.5k total citations
52 papers, 1.1k citations indexed

About

David R. Strayer is a scholar working on Molecular Biology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, David R. Strayer has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Immunology and 12 papers in Psychiatry and Mental health. Recurrent topics in David R. Strayer's work include Fibromyalgia and Chronic Fatigue Syndrome Research (12 papers), interferon and immune responses (6 papers) and DNA and Nucleic Acid Chemistry (6 papers). David R. Strayer is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (12 papers), interferon and immune responses (6 papers) and DNA and Nucleic Acid Chemistry (6 papers). David R. Strayer collaborates with scholars based in United States, Italy and Germany. David R. Strayer's co-authors include William A. Carter, Isadore Brodsky, William M. Mitchell, Staci R. Stevens, Daniel L. Peterson, David Gillespie, Christopher R. Snell, J. Mark VanNess, Edward Pequignot and Diane Young and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

David R. Strayer

51 papers receiving 1.0k citations

Peers

Countries citing papers authored by David R. Strayer

Since Specialization

Citations

This map shows the geographic impact of David R. Strayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Strayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Strayer more than expected).

Fields of papers citing papers by David R. Strayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Strayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Strayer. The network helps show where David R. Strayer may publish in the future.

Co-authorship network of co-authors of David R. Strayer

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Strayer. A scholar is included among the top collaborators of David R. Strayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Strayer. David R. Strayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma. 2024 ·Journal of Clinical Oncology ·Kelsey Klute, Vincent J. Picozzi, Nashat Gabrail, Michael A. Hollingsworth, Christopher W. McAleer, Diane Young, David R. Strayer	2
2	Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action 2023 ·Antiviral Research ·Angela Corona, David R. Strayer, Simona Distinto, (unknown), (unknown), Enzo Tramontano, William M. Mitchell	2
3	Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2020 ·PLoS ONE ·David R. Strayer, Diane Young, William M. Mitchell	19
4	Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans 2014 ·Vaccine ·Edgar T. Overton, Paul A. Goepfert, (unknown), William A. Carter, Joseph Horváth, Diane Young, David R. Strayer	47
5	Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa 2014 ·Antiviral Research ·David R. Strayer, William A. Carter, Bruce C. Stouch, Koert J. Stittelaar, (unknown), Albert D. M. E. Osterhaus, William M. Mitchell	4
6	Discordant Biological and Toxicological Species Responses to TLR3 Activation 2014 ·American Journal Of Pathology ·William M. Mitchell, Christopher F. Nicodemus, William A. Carter, Joseph Horváth, David R. Strayer	22
7	Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment 2013 ·Expert Review of Anti-infective Therapy ·Qinfang Liu, Jingjiao Ma, David R. Strayer, William M. Mitchell, William A. Carter, Wenjun Ma, Jüergen A. Richt	15
8	A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome 2012 ·PLoS ONE ·David R. Strayer, William A. Carter, Bruce C. Stouch, Staci R. Stevens, Lucinda Bateman, (unknown), Charles W. Lapp, Daniel L. Peterson, William M. Mitchell, (unknown)	63
9	Recombinant and Natural Human Interferons: Analysis of the Incidence and Clinical Impact of Neutralizing Antibodies 2011 ·Journal of Interferon & Cytokine Research ·David R. Strayer, William A. Carter	9
10	Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus 2010 ·Journal of Medical Virology ·Takeshi Ichinohe, Akira Ainai, Yasushi Ami, Noriyo Nagata, Naoko Iwata, Akira Kawaguchi, Yuriko Suzaki, Takato Odagiri, Masato Tashiro, Hidehiro Takahashi, David R. Strayer, William A. Carter, Joe Chiba, Shinichi Tamura, Tetsutaro Sata, Takeshi Kurata, Hideki Hasegawa	39
11	Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine 2007 ·The Journal of Infectious Diseases ·Takeshi Ichinohe, Shinichi Tamura, Akira Kawaguchi, Ai Ninomiya, Masaki Imai, Shigeyuki Itamura, Takato Odagiri, Masato Tashiro, Hidehiro Takahashi, Hirofumi Sawa, William M. Mitchell, David R. Strayer, William A. Carter, Joe Chiba, Takeshi Kurata, Tetsutaro Sata, Hideki Hasegawa	107
12	Variability of repeated exercise testing in patients with chronic fatigue syndrome 2000 ·The FASEB Journal ·Christopher R. Snell, (unknown), (unknown), David R. Strayer, (unknown), Staci R. Stevens	1
13	Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection 1996 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), David R. Strayer, (unknown), (unknown), Nancy G. Klimas, (unknown), (unknown), Zhihua Zheng, Daniel Ventura, (unknown)	74
14	RNA Drug Therapy Acting via the 2–5A Synthetase/RNase L Pathway 1993 ·Annals of the New York Academy of Sciences ·Robert J. Suhadolnik, Nancy L. Reichenbach, (unknown), Dharam V. Ablashi, David R. Strayer, (unknown)	1
15	Specific RNA Drug Therapy of Hepatitis Viruses 1993 ·Annals of the New York Academy of Sciences ·William A. Carter, Robert J. Suhadolnik, Wernér E.G. Müller, Brent E. Korba, Howard R. Hubbell, Gabriel García, David R. Strayer	2
16	Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft 1992 ·Cancer Immunology Immunotherapy ·Howard R. Hubbell, Hugo E. Vargas, (unknown), (unknown), Edward Pequignot, Robert D. Bigler, William A. Carter, David R. Strayer	4
17	Growth of Astrocytomas in the Human Tumor Clonogenic Assay and Sensitivity to Mismatched dsRNA and Interferons 1987 ·American Journal of Clinical Oncology ·David R. Strayer, (unknown), William A. Carter, Perry Black, (unknown), Albert W. Cook	6
18	Antiproliferative Effect of Mismatched Double-Stranded RNA on Fresh Human Tumor Cells Analyzed in a Clonogenic Assay 1986 ·Journal of Interferon Research ·David R. Strayer, (unknown), William A. Carter, Isadore Brodsky	10
19	Antiproliferative Effect of Natural Beta Interferon on Fresh Tumor Cells Analyzed in a Clonogenic Assay 1984 ·Journal of Interferon Research ·David R. Strayer, (unknown), William A. Carter, Isadore Brodsky	5
20	The Nature and Organization of Retroviral Genes in Animal Cells 1980 ·PubMed ·David R. Strayer, David Gillespie	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact